SecurityAKAO / Achaogen, Inc. (004449104)
Institutional Owners117 (7 N-Q Owners)
Institutional Shares45,163,155 - 100.98% (ex. N-Q)
Institutional Value$ 14,062,275,000 USD (ex. N-Q)

Institutional Stock Ownership and Shareholders

Achaogen, Inc. (NASDAQ:AKAO) has 117 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 45,163,155 shares. Largest shareholders include Duggan Robert W, NEA Management Company, LLC, FMR LLC / Fidelity, BlackRock Inc., State Street Corp, Foresite Capital Management III, LLC, Foresite Capital Fund III, L.P., Polar Capital LLP, Venrock Partners, L.p., and Vanguard Group Inc.

Achaogen, Inc. (NASDAQ:AKAO) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.


File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-04-18 13F-HR Creative Planning 0 71,160 0 922
2018-02-20 13F-HR/A-1 ALPS ADVISORS INC 41,593 0 -100.00 663 0 -100.00
2018-04-13 13F-HR BANK OF MONTREAL /CAN/ Put 9,000 29,000 222.22 97 376 287.63
2018-02-14 13F-HR Weiss Multi-Strategy Advisers LLC 35,500 35,000 -1.41 566 376 -33.57
2017-12-14 13F-HR/A-1 PARAMETRIC PORTFOLIO ASSOCIATES LLC 47,917 0 -100.00 1,041 0 -100.00
2017-11-13 13F-HR Spark Investment Management LLC 236,700 0 -100.00 5,143 0 -100.00
2018-02-13 13F-HR Foresite Capital Management III, LLC 1,912,106 2,375,000 24.21 30,498 25,508 -16.36
2018-02-14 13F-HR ROYAL BANK OF CANADA 3,491 677 -80.61 56 8 -85.71
2018-02-02 13F-HR US BANCORP \DE\ 2,603 6,119 135.07 42 66 57.14
2018-02-14 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 54,466 53,853 -1.13 869 578 -33.49
2018-02-14 13F-HR Invesco Ltd. 13,228 0 -100.00 211 0 -100.00
2018-01-17 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 122,684 137,716 12.25 1,957 1,480 -24.37
2018-04-18 13F-HR/A-1 FNY Managed Accounts LLC Call 4 0
2018-02-14 13F-HR Quantitative Investment Management, LLC 133,500 1,433
2018-02-09 13F-HR GROUP ONE TRADING, L.P. Put 132,200 118,300 -10.51 2,109 1,271 -39.73
2018-02-09 13F-HR GREAT WEST LIFE ASSURANCE CO /CAN/ 2,200 2,200 0.00 36 24 -33.33
2018-02-14 13F-HR UBS Group AG 56,954 38,086 -33.13 908 409 -54.96
2018-02-09 13F-HR RHUMBLINE ADVISERS 34,580 31,550 -8.76 552 339 -38.59
2018-02-01 13F-HR STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 16,486 16,696 1.27 263 179 -31.94
2018-01-10 13F-HR SIMPLEX TRADING, LLC Put 703 362 -48.51 98 118 20.41
2018-02-14 13F-HR NORTHERN TRUST CORP 381,078 376,021 -1.33 6,078 4,038 -33.56
2018-02-09 13F-HR Fiera Capital Corp 224,211 181,164 -19.20 3,576 1,945 -45.61
2018-02-14 13F-HR PRICE T ROWE ASSOCIATES INC /MD/ 938,876 947,056 0.87 14,975 10,171 -32.08
2018-02-13 13F-HR Axa 80,584 442,921 449.64 1,285 4,757 270.19
2018-02-13 13F-HR EMORY UNIVERSITY 100,821 0 -100.00 1,608 0 -100.00
2018-02-14 13F-HR Pacer Advisors, Inc. 2,075 22
2018-04-20 13F-HR Cable Hill Partners, LLC 800 2,000 150.00 9 24 166.67
2018-02-14 13F-HR LORD, ABBETT & CO. LLC 411,992 366,247 -11.10 6,571 3,933 -40.15
2018-01-24 13F-HR IFP Advisors, Inc 219 2
2018-02-14 13F-HR BLAIR WILLIAM & CO/IL 12,154 0 -100.00 194 0 -100.00
2017-11-14 13F-HR ARDSLEY ADVISORY PARTNERS 10,000 0 -100.00 217 0 -100.00
2018-02-14 13F-HR Point72 Asia (Hong Kong) Ltd 1,391 0 -100.00 22 0 -100.00
2018-01-23 13F-HR Clear Harbor Asset Management, LLC 16,511 177
2018-02-07 13F-HR Marcus Capital, LLC 53,650 17,400 -67.57 856 187 -78.15
2018-01-10 13F-HR SIMPLEX TRADING, LLC 24,063 7,797 -67.60 383 83 -78.33
2018-04-16 13F-HR Raymond James Financial Services Advisors, Inc. 103,340 93,190 -9.82 1,110 1,207 8.74
2018-02-09 13F-HR Stanley-Laman Group, Ltd. 69,889 751
2018-02-14 13F-HR GOLDMAN SACHS GROUP INC 321,772 331,039 2.88 5,132 3,555 -30.73
2018-03-14 SC 13D/A DUGGAN ROBERT W 6,347,318 6,347,318 0.00
2017-11-07 13F-HR AMERIPRISE FINANCIAL INC 44,184 0 -100.00 960 0 -100.00
2018-02-02 13F-HR GABELLI FUNDS LLC 61,800 61,800 0.00 986 664 -32.66
2018-02-09 13F-HR CITADEL ADVISORS LLC 736,089 32,005 -95.65 11,740 344 -97.07
2018-02-14 13F-HR DSC Advisors, L.P. 70,000 752
2017-11-06 13F-HR Sigma Planning Corp 9,450 0 -100.00 205 0 -100.00
2017-11-29 N-Q Gabelli Healthcare & Wellnessrx Trust (see advisory)
2018-02-13 13F-HR Oz Management LP 49,400 531
2018-02-13 13F-HR ALLIANCEBERNSTEIN L.P. 107,400 117,400 9.31 1,713 1,261 -26.39
2018-02-08 13F-HR STATE OF WISCONSIN INVESTMENT BOARD 22,000 22,000 0.00 351 236 -32.76
2017-11-14 13F-HR TUDOR INVESTMENT CORP ET AL 163,968 0 -100.00 3,563 0 -100.00
2018-02-14 13F-HR ELLINGTON MANAGEMENT GROUP LLC 0 16,500 0 177
2018-02-13 13F-HR Winch Advisory Services, LLC 200 2
2018-02-01 13F-HR Engineers Gate Manager LP 0 38,395 0 412
2018-02-07 13F-HR OPPENHEIMER ASSET MANAGEMENT INC. 7,603 0 -100.00 121 0 -100.00
2018-04-10 13F-HR Gierl Augustine Investment Management Inc 1,000 1,000 0.00 11 13 18.18
2018-02-13 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 32,500 32,500 0.00 518 349 -32.63
2018-02-01 SC 13G BlackRock Inc. 2,837,846
2018-01-10 SC 13G/A Baker Brothers Advisors LP 4,582,382 122,482 -97.33
2018-02-09 13F-HR Artal Group S.A. 250,000 250,000 0.00 3,988 2,685 -32.67
2018-02-12 13F-HR Financial Architects, Inc 1,950 2,603 33.49 31 28 -9.68
2017-10-26 13F-HR Raymond James Financial Services Advisors, Inc. Call 102,800 0 -100.00 108 0 -100.00
2018-02-02 13F-HR FIRST MIDWEST BANK TRUST DIVISION 46,036 374,007 712.42 734 4,017 447.28
2018-02-13 13F-HR GEODE CAPITAL MANAGEMENT, LLC 293,612 294,718 0.38 4,683 3,165 -32.42
2018-02-07 13F-HR Swiss National Bank 44,300 44,300 0.00 707 476 -32.67
2018-02-22 13F-HR Wagner Wealth Management, Llc 0 1
2018-04-16 13F-HR Raymond James Financial Services Advisors, Inc. Put 36,100 31,900 -11.63 357 242 -32.21
2018-02-08 13F-HR NEA Management Company, LLC 5,215,128 5,215,128 0.00 83,181 56,010 -32.66
2018-02-07 13F-HR Candriam Luxembourg S.C.A. 182,555 172,555 -5.48 2,912 1,853 -36.37
2018-03-14 13F-HR/A-1 CREDIT SUISSE AG/ 48,211 29,567 -38.67 769 317 -58.78
2018-02-08 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 26,943 26,721 -0.82 430 287 -33.26
2018-02-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Call 86,800 101,500 16.94 1,384 1,090 -21.24
2018-02-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Put 76,800 188,800 145.83 1,225 2,028 65.55
2018-02-13 13F-HR Legal & General Group Plc 8,645 8,645 0.00 137 93 -32.12
2017-10-30 13F-HR ESSEX INVESTMENT MANAGEMENT CO LLC 26,330 0 -100.00 572 0 -100.00
2018-01-25 13F-HR Versant Venture Management, LLC 1,281,152 1,281,152 0.00 20,600,924 13,759,572 -33.21
2017-11-14 13F-HR SPRINGBOK CAPITAL MANAGEMENT, LLC 14,097 0 -100.00 306 0 -100.00
2018-02-14 13F-HR HARBOURVEST PARTNERS LLC 20,000 20,000 0.00 319 215 -32.60
2017-11-08 13F-HR EAM Investors, LLC 151,522 0 -100.00 3,293 0 -100.00
2017-11-14 13F-HR BANK OF NOVA SCOTIA 80,061 0 -100.00 1,740 0 -100.00
2018-02-09 13F-HR Bank of New York Mellon Corp 139,844 144,843 3.57 2,231 1,555 -30.30
2018-03-02 13F-HR International Biotechnology Trust Plc 74,538 204,538 174.41 1,189 2,197 84.78
2018-02-13 13F-HR Oz Management LP Put 49,400 531
2018-02-08 13F-HR SEI INVESTMENTS CO 88,000 88,000 0.00 1,404 945 -32.69
2017-11-28 N-Q Jnl Variable Fund Llc (see advisory)
2018-02-14 13F-HR ProShare Advisors LLC 27,911 300
2017-11-02 13F-HR/A-1 Advisor Group, Inc. 357 0 -100.00 1 0 -100.00
2018-02-13 13F-HR Renaissance Technologies LLC 18,800 642,700 3,318.62 300 6,903 2,201.00
2018-02-14 13F-HR NEXTHERA CAPITAL LP 577,766 0 -100.00 9,215 0 -100.00
2018-02-14 13F-HR PERCEPTIVE ADVISORS LLC 27,551 0 -100.00 439 0 -100.00
2018-02-14 13F-HR AQR CAPITAL MANAGEMENT LLC 33,394 26,041 -22.02 533 280 -47.47
2018-02-28 N-Q Ishares Trust (see advisory)
2018-02-08 13F-HR WELLS FARGO & COMPANY/MN 33,213 50,683 52.60 530 545 2.83
2018-02-13 SC 13G/A Foresite Capital Fund III, L.P. 2,607,984 2,375,000 -8.93
2018-02-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 0 128,313 0 1,378
2018-02-14 SC 13G/A Venrock Partners, L.p. 1,746,461
2018-01-31 13F-HR Zurcher Kantonalbank (Zurich Cantonalbank) 1,712 18
2018-02-09 13F-HR AMERICAN INTERNATIONAL GROUP INC 19,445 23,013 18.35 310 247 -20.32
2018-01-12 13F-HR Hikari Power Ltd 30,000 60,000 100.00 479 644 34.45
2018-01-29 13F-HR REILLY FINANCIAL ADVISORS, LLC 100 0 -100.00 2 0 -100.00
2018-01-17 13F-HR Cutler Group LP Call 400 3,400 750.00 0 1
2018-04-09 13F-HR CONTRAVISORY INVESTMENT MANAGEMENT, INC. 27 0 -100.00 0 0
2018-02-14 SC 13G/A Point72 Asset Management, L.P. 2,230,165 1,502,400 -32.63
2018-02-09 13F-HR CITADEL ADVISORS LLC Put 33,500 58,700 75.22 534 630 17.98
2018-02-09 13F-HR RidgeWorth Capital Management LLC 0 31,243 0 336
2018-02-14 13F-HR BANK OF AMERICA CORP /DE/ 92,974 44,121 -52.54 1,482 474 -68.02
2018-02-14 13F-HR TEACHERS ADVISORS INC 54,346 62,483 14.97 867 671 -22.61
2017-11-27 13F-HR/A-1 SPHERA FUNDS MANAGEMENT LTD. 75,000 0 -100.00 1,630 0 -100.00
2018-02-14 13F-HR MORGAN STANLEY 182,601 226,560 24.07 2,913 2,433 -16.48
2017-11-14 13F-HR UBS OCONNOR LLC 78,697 0 -100.00 1,710,000 0 -100.00
2018-01-17 13F-HR Cutler Group LP 200 1,400 600.00 3 15 400.00
2018-01-22 13F-HR HARTWELL J M LIMITED PARTNERSHIP 14,000 0 -100.00 223 0 -100.00
2017-11-29 N-Q Vanguard Valley Forge Funds (see advisory)
2018-02-13 SC 13G STATE STREET CORP 2,383,455
2017-11-14 13F-HR FARALLON CAPITAL MANAGEMENT LLC 948,500 0 -100.00 20,611 0 -100.00
2018-02-15 13F-HR Metlife Investment Advisors, Llc 14,077 151
2018-02-13 13F-HR UNIVERSITY OF NOTRE DAME DU LAC 155,654 0 -100.00 2,483 0 -100.00
2018-02-13 13F-HR Allianz Asset Management AG 51,120 51,035 -0.17 815 548 -32.76
2018-02-27 N-Q GABELLI EQUITY SERIES FUNDS INC (see advisory)
2018-02-08 13F-HR Trexquant Investment LP 0 47,742 0 513
2018-04-18 13F-HR REGIONS FINANCIAL CORP 4,500 0 -100.00 48 0 -100.00
2018-01-17 13F-HR Cutler Group LP Put 0 3,700 0 6
2018-02-14 13F-HR METROPOLITAN LIFE INSURANCE CO/NY 20,412 10,899 -46.60 326 117 -64.11
2018-02-14 13F-HR Alyeska Investment Group, L.P. 0 300,000 0 3,222
2018-02-09 13F-HR CITADEL ADVISORS LLC Call 0 29,800 0 320
2018-02-14 13F-HR HIGHBRIDGE CAPITAL MANAGEMENT LLC Call 19,100 0 -100.00 304 0 -100.00
2018-02-13 SC 13G/A FMR LLC / Fidelity 4,799,665 5,032,176 4.84
2018-02-09 13F-HR GROUP ONE TRADING, L.P. Call 3,000 5,300 76.67 48 57 18.75
2018-02-14 13F-HR VANGUARD GROUP INC 1,531,127 1,546,004 0.97 24,422 16,604 -32.01
2018-02-13 13F-HR Prosight Management, LP 570,920 6,132
2017-11-06 13F-HR Sanctuary Wealth Advisors, LLC 328 0 -100.00 7 0 -100.00
2018-02-14 13F-HR ICONIQ Capital, LLC 28,629 28,629 0.00 457 307 -32.82
2018-02-14 13F-HR Schonfeld Strategic Advisors LLC 476,199 128,155 -73.09 7,595 1,377 -81.87
2018-02-13 13F-HR Wellington Management Group LLP 0 43,875 0 471
2018-02-07 13F-HR SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 600 600 0.00 10 6 -40.00
2018-02-14 13F-HR Cubist Systematic Strategies, LLC 900 0 -100.00 14 0 -100.00
2018-04-17 13F-HR BENJAMIN F. EDWARDS & COMPANY, INC. 800 10
2018-02-14 13F-HR Voya Investment Management LLC 15,435 15,435 0.00 246 166 -32.52
2018-04-18 13F-HR Sonora Investment Management, LLC 1,000 1,000 0.00 10,740 12,950 20.58
2018-02-14 13F-HR Ameritas Investment Partners, Inc. 2,546 2,546 0.00 47 27 -42.55
2018-02-14 13F-HR Squarepoint Ops LLC 0 28,487 0 306
2018-02-14 13F-HR BARCLAYS PLC 31,402 14,593 -53.53 501 157 -68.66
2018-02-06 13F-HR Russell Investments Group, Ltd. 10,092 0 -100.00 161 0 -100.00
2018-02-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 86,614 79,911 -7.74 1,381 858 -37.87
2018-04-20 13F-HR Steward Partners Investment Advisory, Llc 7,650 11,675 52.61 82 151 84.15
2017-11-13 13F-HR FRANKLIN RESOURCES INC 400,000 0 -100.00 8,692 0 -100.00
2018-02-14 13F-HR DEUTSCHE BANK AG\ 126,980 517,221 307.32 2,024 5,553 174.36
2018-03-05 13F-HR/A-1 BNP PARIBAS ARBITRAGE, SA 2,920 7,287 149.55 46,574 78,262 68.04
2018-04-13 13F-HR BANK OF MONTREAL /CAN/ 21,000 31,000 47.62 225 402 78.67
2018-02-14 13F-HR Premier Asset Managment LLC 36,216 389
2018-02-12 13F-HR CITIGROUP INC 58,127 92,949 59.91 927 998 7.66
2018-02-09 13F-HR Tower Research Capital LLC (TRC) 3,923 18,648 375.35 62 201 224.19
2017-11-15 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 11,200 0 -100.00 243 0 -100.00
2018-02-02 13F-HR TD ASSET MANAGEMENT INC 39,726 39,226 -1.26 634 421 -33.60
2017-11-14 13F-HR MILLENNIUM MANAGEMENT LLC 22,770 0 -100.00 495 0 -100.00
2018-02-13 13F-HR AWM Investment Company, Inc. 120,200 0 -100.00 1,917 0 -100.00
2018-02-12 13F-HR Pacad Investment Ltd. 17,800 0 -100.00 284 0 -100.00
2017-11-14 13F-HR BARCLAYS PLC Call 1,000 0 -100.00 22 0 -100.00
2018-02-09 13F-HR GROUP ONE TRADING, L.P. 87,408 94,980 8.66 1,394 1,020 -26.83
2018-02-14 SC 13G/A Polar Capital LLP 1,750,000 1,881,380 7.51
2018-01-17 13F-HR HAMILTON LANE ADVISORS LLC 11,428 0 -100.00 182 0 -100.00
2018-02-14 13F-HR Parallax Volatility Advisers, L.P. 5,308 57
2018-02-14 13F-HR TimesSquare Capital Management, LLC 1,361,665 1,367,965 0.46 21,719 14,692 -32.35
2018-02-12 13F-HR Hudson Bay Capital Management LP 90,000 0 -100.00 1,436 0 -100.00
2018-02-13 13F-HR JP Morgan Chase & Co 3,700 11,070 199.19 60 119 98.33
2018-02-01 13F-HR Nationwide Fund Advisors 18,843 0 -100.00 301 0 -100.00
2018-02-14 13F-HR Iguana Healthcare Management, LLC 30,000 75,000 150.00 479 806 68.27
2017-11-07 13F-HR SG Americas Securities, LLC 16,650 0 -100.00 362 0 -100.00
2017-11-29 N-Q Vanguard Institutional Index Funds (see advisory)
2018-02-02 13F-HR Ballentine Partners, LLC 19,823 19,823 0.00 316 213 -32.59
2017-11-29 N-Q Vanguard Index Funds (see advisory)
2018-04-10 13F-HR CHESLEY TAFT & ASSOCIATES LLC/IL 18,075 234
2018-02-14 13F-HR TWO SIGMA INVESTMENTS LLC 24,243 260
2017-11-13 13F-HR Nicholas Investment Partners, LP 180,871 0 -100.00 3,931 0 -100.00

Form N-Q Advisory - Experimental Feature Here!

We have recently started to include coverage of N-Q filers in our ownership database. N-Q forms are unstructured and difficult for machines to parse into accurate financial data.

However, Because of the large number of these institutions and this difficulty in tracking their positions, they represent a significant, yet hidden, market force. In an effort to widen our ownership coverage and provide greater transparency, we are testing various ways to expose these owners in an accurate manner. This early version of the crawler simply identifies mentions of companies in the N-Q forms.

Limitations:

  • We only list underlying securities (the ordinary shares), even though the actual security held might be a derivative or a related bond issue. For example, although the institution is shown on this security page ( AKAO / Achaogen, Inc. ), the institution may actually own a related security such as a preferred share or a bond. To find out the exact security, click on the institution link and then follow the link to the actual "N-Q".
  • We only list fund sponsors as institutions, even though the security might be held within a fund operated by the listed institution.. For example, the institution listed in the table as the owner is probably a sponsor of a family of ETFs or mutual funds. If so, then this security is owned by a fund or several funds within the family, and not directly owned by the listed institution. The crawler is not yet able to place these holdings within the individual funds. Atain, you must review the actual filing to see the detail.

These limitations are significant but we believe that the increased transparency outweights the limitations. Future revisions of the crawler will resolve these limitations. Use this information at your own risk!

AKAO : Achaogen Stock Analysis and Research Report

2017-11-08 - Asif

Achaogen is a late-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization of novel antibacterial treatments against multi-drug resistant (“MDR”) gram-negative infections. Achaogen is researching and developing plazomicin, its lead product candidate, for the treatment of serious bacterial infections, including complicated urinary tract infection (“cUTI”), blood stream infections and other infections due to MDR Enterobacteriaceae, including carbapenem-resistant Enterobacteriaceae (“CRE”). In 2013, the Centers for Disease Control and Prevention identified CRE as a “nightmare bacteria” and an immediate public health threat that requires “urgent and aggressive action” and in 2017 the World Health Organization identified CRE as a Global Priority 1 Pathogen: Critical Need for Research and Development of New Antibiotics. On December 12, 2016, the company announced positive data from its two Phase 3 clinical trials for plazomicin. The firs...

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 004449104